, Yosuke Tsuji
, Hikaru Kuribara
, Ryohei Miyata
, Kaori Oshio
, Satoru Mizutani
, Hideki Nakagawa
, Rina Cho
, Nobuyuki Sakuma
, Yuko Miura
, Hiroya Mizutani
, Daisuke Ohki
, Seiichi Yakabi
, Yu Takahashi
, Yoshiki Sakaguchi
, Naomi Kakushima
, Nobutake Yamamichi
, Mitsuhiro Fujishiro
Citations

, Daria Yunina
, Anna Abbasi
, Kevin Tin
, Daniel Simkin
, Mary Rojas
, Yuriy Tsirlin
, Ira Mayer
, Rabin Rahmani
Citations

, Kevin Tin
, Steven Guttmann
, Anna A Abbasi
, Ira Mayer
, Yuriy Tsirlin
Citations

Despite improvements in endoscopic hemostasis and pharmacological therapies, upper gastrointestinal (UGI) ulcers repeatedly bleed in 10% to 20% of patients, and those without early endoscopic reintervention or definitive surgery might be at a high risk for mortality. This study aimed to identify the risk factors for intractability to initial endoscopic hemostasis.
We analyzed intractability among 428 patients who underwent emergency endoscopy for bleeding UGI ulcers within 24 hours of arrival at the hospital.
Durable hemostasis was achieved in 354 patients by using initial endoscopic procedures. Sixty-nine patients with Forrest types Ia, Ib, IIa, and IIb at the second-look endoscopy were considered intractable to the initial endoscopic hemostasis. Multivariate analysis indicated that age ≥70 years (odds ratio [OR], 2.06; 95% confidence interval [CI], 1.07 to 4.03), shock on admission (OR, 5.26; 95% CI, 2.43 to 11.6), hemoglobin <8.0 mg/dL (OR, 2.80; 95% CI, 1.39 to 5.91), serum albumin <3.3 g/dL (OR, 2.23; 95% CI, 1.07 to 4.89), exposed vessels with a diameter of ≥2 mm on the bottom of ulcers (OR, 4.38; 95% CI, 1.25 to 7.01), and Forrest type Ia and Ib (OR, 2.21; 95% CI, 1.33 to 3.00) predicted intractable endoscopic hemostasis.
Various factors contribute to intractable endoscopic hemostasis. Careful observation after endoscopic hemostasis is important for patients at a high risk for incomplete hemostasis.
Citations

Methods: Three hundred patients who visited our hospital for EGD were randomly assigned to three groups (A,B and C). An initial induction dose of 0.5 mg/kg, 0.75 mg/kg and 1.0 mg/kg of propofol was allocated to groups A, B and C, respectively.
Results: The 0.5 mg/kg, 0.75 mg/kg and, 1 mg/kg dose of propofol were all safe as an initial dose of propofol for achieving sedation during EGD in persons 60 years or older. There was no difference in the total amount of propofol among the three groups. Group C had a significantly shorter induction time and a lower dose was required for an additional injection of propofol without increasing adverse events, as compared to the two other groups.
Conclusions: We suggest that 1 mg/kg of propofol is an effective induction dose for sedation during EGD in persons 60 years or older. (Korean J Gastrointest Endosc 2010;40:134-139)

